ALDX · Aldeyra Therapeutics, Inc.
$1.56
+0.00 (+0.00%)
At close · Aug 17
Market Cap
$94.11M
Shares
60.33M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-08-12 | Machatha Stephen | Officer | 22,074 | 2025-08-12 | Morgan Stanley Smith Barney LLC |
| 2024-08-12 | Greenberg Bruce | Officer | 10,834 | 2024-08-12 | Morgan Stanley Smith Barney LLC |
| 2024-08-12 | Machatha Stephen | Officer | 16,041 | 2024-08-12 | Morgan Stanley Smith Barney LLC |
| 2024-03-12 | STEPHEN G. MACHATHA | Officer | 11,537 | 2024-03-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-11 | Machatha Stephen | Officer | 18,231 | 2024-03-11 | Morgan Stanley Smith Barney LLC |
| 2024-03-11 | Brady Todd C | Officer | 183,238 | 2024-03-11 | MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICES |
| 2024-03-11 | Greenberg Bruce | Officer | 13,201 | 2024-03-11 | Morgan Stanley Smith Barney LLC |
Showing 1–7 of 7 filings
Key facts
CIK
1341235
CUSIP
01438T106
13F (30d)
108 filings
99 filers
Visit website
Investor relations